March 14, 2024
12 min listen
Save
Healio Minute Podcast, Lung Cancer Edition: Top Headlines - Week of March 11, 2024
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this edition, race identified as risk factor for VTE, FDA approves Rybrevant for treatment of non-small cell lung cancer and more.
Read the full coverage here:
Race identified as risk factor for VTE after pulmonary resection for lung cancer
FDA approves Rybrevant for treatment of non-small cell lung cancer
Behavioral health disorders have a ‘big impact’ on cancer surgery outcomes
Optimizing immunotherapy, biomarker testing vital to progress in lung cancer treatment
FDA approves Tagrisso plus chemotherapy for EGFR-mutated non-small cell lung cancer
References:
Axtell AL, et al. Ann Thorac Surg. 2024;doi:10.1016/j.athoracsur.2024.01.005.
Katayama ES, et al. J Am Coll Surgeons. 2024;doi:10.1097/XCS.0000000000000954.
Published by:
Sources/Disclosures
Collapse
Disclosures:
Please see each study for relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
